tldrdailynews.com logo
Tag

Rezdiffra

All articles tagged with #rezdiffra

Green Mediterranean Plan Reverses Fatty Liver and Boosts Weight Loss
wellness4 days ago

Green Mediterranean Plan Reverses Fatty Liver and Boosts Weight Loss

MASLD (formerly NAFLD) can improve with lifestyle changes and, for some patients, medications. The article recommends swapping refined carbs for leafy greens and liver-friendly foods like avocado, berries, apples, eggs, wild salmon, walnuts and flaxseed; adopting a Green Mediterranean pattern rich in polyphenols; sipping coffee or green tea and avoiding drinks with added sugar; moving about 30 minutes most days plus more daily steps; prioritizing 7–8 hours of sleep, finishing meals 2–3 hours before bed, and using a 10-hour eating window; and, for certain patients, prescription rezdiffera/resmetirom (FDA-approved for NASH). Ozempic is used off-label by some clinicians to address obesity/insulin resistance, and statins may lower cardiovascular risk in MASLD. Many readers report improved liver fat and weight loss with these strategies, but medical guidance is essential for personalized care.

via Woman's World|
#green-mediterranean-diet#masld#nafld
"FDA Approves Madrigal Pharmaceuticals' Rezdiffra as First Treatment for Common NASH Liver Disease"
health2 years ago

"FDA Approves Madrigal Pharmaceuticals' Rezdiffra as First Treatment for Common NASH Liver Disease"

The FDA has approved the first medication, Rezdiffra, for nonalcoholic steatohepatitis (NASH), a common form of liver inflammation associated with obesity and metabolic conditions. The medication, developed by Madrigal Pharmaceuticals, showed promising results in reducing fat accumulation in the liver and achieving NASH resolution with no worsening of fibrosis in clinical trials. It is intended to be used alongside a healthy diet and exercise and is expected to be available next month. The approval marks a significant milestone in NASH treatment and offers hope for patients and healthcare providers.

via CNN|
#fda#health#liver-inflammation
"FDA Approves First Drug for Common Liver Disease NASH"
health2 years ago

"FDA Approves First Drug for Common Liver Disease NASH"

The FDA has approved Rezdiffra, the first drug developed specifically to treat the liver disease MASH, which is associated with obesity and can lead to serious complications such as liver scarring and cancer. The pill, made by Madrigal Pharmaceuticals, aims to address the accumulation of fat in the liver that causes inflammation and fibrosis, offering a potential treatment for this serious condition.

via STAT|
#fda#health#liver-disease
"FDA Greenlights First-Ever Drug for Fatty Liver Disease NASH"
health2 years ago

"FDA Greenlights First-Ever Drug for Fatty Liver Disease NASH"

The FDA has approved Rezdiffra (resmetirom) as the first treatment for adults with noncirrhotic non-alcoholic steatohepatitis (NASH) and moderate to advanced liver scarring, to be used alongside diet and exercise. NASH, a result of nonalcoholic fatty liver disease, can lead to liver scarring and dysfunction. Rezdiffra, a partial activator of a thyroid hormone receptor, showed promising results in reducing liver fat accumulation in a 54-month trial. Common side effects include diarrhea and nausea, and precautions include drug-induced liver toxicity and gallbladder-related side effects. The approval was granted under the accelerated approval pathway, and a postapproval study is ongoing to assess clinical benefit after 54 months of treatment.

via FDA.gov|
#fda#health#liver-scarring